Phio Pharmaceuticals Stock Forum

$Phio Pharmaceuticals (PHIO.US)$
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Tuesday, 3rd December at 7:45 am
Registration Link for Presentation and live Q&A to take place, Tuesday, December 10, 2024 at 12:00 pm EST
Marlborough, Massachusetts--(Newsfile Corp. - December 3, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics that use its INTASYL® siRNA gene silenci...

$Phio Pharmaceuticals (PHIO.US)$
Phio Pharmaceuticals Announces Completion of Enrollment in Second Cohort in Phase 1b Dose-Escalating Clinical Study
Phio Pharmaceuticals (NASDAQ: PHIO) has completed enrollment for the second cohort in its PH-762 Phase 1b dose-escalating clinical trial and added a sixth clinical site in San Diego. New data from the trial shows promising results, with one patient achieving complete response (100% tumor clearance) and another achieving partial response (90% tu...

$Phio Pharmaceuticals (PHIO.US)$
Phio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Phio Pharmaceuticals (NASDAQ: PHIO) announced new clinical data presentation from its ongoing Phase 1b trial at the 39th Annual SITC Meeting. The trial evaluates PH-762 through intratumoral injection in patients with various skin cancers. Results show the treatment has been well-tolerated with no adverse events across five patient...

$Phio Pharmaceuticals (PHIO.US)$
Phio Pharmaceuticals Presenting Data on Its INSTAYL Compound PH-894 at ASGCT's 2024 Advancing Gene and Cell Therapies for Cancer Conference
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is presenting data on its INTASYL compound PH-894 at the ASGCT's 2024 Advancing Gene and Cell Therapies for Cancer conference. The presentation focuses on how PH-894 improves the functionality and cytotoxicity of Natural Killer (NK) cells in fighting cancer:
1. PH-894 leads to pote...

$Phio Pharmaceuticals (PHIO.US)$ pos til it's not 2.90 to 5.80 sometime

$Phio Pharmaceuticals (PHIO.US)$ someone tell Moomoo put the damn B on the price not the wick, looks like i bought at 4.15, i bought the bounce back to the level it was at incase it took off.. god damn.. i'd average down but all 3 doing the same shit lol.. this, BFRI and MLGO sitting red af lol.. everything on my list that isnt a position green.. 3 I own are red.. not rigged or anything.. target pumpers not me :P who buys all this shit

$Phio Pharmaceuticals (PHIO.US)$  helps within 10 minutes.. anyone try it yet, asking for a friend (not this ticker but you know it could use some)

$Phio Pharmaceuticals (PHIO.US)$ comical normal shit.. all Bio's run later today or later in the week together watch.. BFRI BDRX this and more.. Dark Pool Active af, buy orders dark pool or rerouted and Sell Orders filled lmfao.. relax and hold, nothing new, normal SEC Activity going on here, $MicroAlgo (MLGO.US)$ $Biofrontera (BFRI.US)$ $Nova Vision Acquisition Corp (NOVV.US)$.. and more

$Phio Pharmaceuticals (PHIO.US)$ Buy the dip